Stay updated with breaking news from Research Square. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A new study has pointed out that Molnupiravir treatment increases the ratio of transition to transversion mutations in COVID-19 patients and that the treatment does not appear to induce resistance mutations in the SARS-CoV-2 genome.
Individuals with a history of Lyme disease, caused by tick bites are at a higher risk of severe COVID-19.
A new study showed that 7DW8-5, an immunostimulatory glycolipid impeded three respiratory viral infections, including SARS-CoV-2, in vivo.
Plus: Another Rockville office complex being converted to life science labs
Researchers observed lower susceptibility of children and adolescents to SARS-CoV-2 infection.